• News mega-p
  • Press Release mega-p
  • Careers mega-p
      • Life at Hikal
      • Career Opportunities
  • Contact Us mega-p
      • Visit us
      • Get in touch
  • About
      • Who We Are
      • Mission & Vision
      • The Hikal Way
      • Sustainability
      • Team Hikal
      • Facilities
  • Pharmaceuticals
      • Offerings
      • Contract Development &
        Manufacturing
      • APIs and Intermediates
      • Animal Health
      • Project Management
      • Facilities
  • Crop Protection
      • Overview
      • Offerings
      • Capabilities
      • Project Management
      • Facilities
  • Specialty Chemicals
      • Offerings
      • Facilities
    • Research & Technology
        • Overview
        • Infrastructure
        • Scientific Advisory Board
        • Facility
      • Investor Relations
          • Presentations
          • Investor Information
            • Company Fact Sheet
            • Company Announcements
            • Shareholding Pattern
            • EOGM
            • TDS on Dividend
            • IEPF/Dividend/ Share
            • Investor Services Forms
          • Financials
            • Annual Reports
            • Financial Results
            • Press Release
            • Financial Highlights
            • Investor Call Transcripts
            • Related Party Transactions
          • Investor's Contact
          • Corporate Governance
          • AGM
          • Postal Ballot
        certified-logo.png
        • About
            • Who We Are
            • Mission & Vision
            • The Hikal Way
            • Sustainability
            • Team Hikal
            • Facilities
        • Pharmaceuticals
            • Offerings
            • Contract Development &
              Manufacturing
            • APIs and Intermediates
            • Animal Health
            • Project Management
            • Facilities
        • Crop Protection
            • Overview
            • Offerings
            • Capabilities
            • Project Management
            • Facilities
        • Specialty Chemicals
            • Offerings
            • Facilities
        • Research & Technology
            • Overview
            • Infrastructure
            • Scientific Advisory Board
            • Facility
        • Investor Relations
            • Presentations
            • Investor Information
              • Company Fact Sheet
              • Company Announcements
              • Shareholding Pattern
              • EOGM
              • TDS on Dividend
              • IEPF/Dividend/ Share
              • Investor Services Forms
            • Financials
              • Annual Reports
              • Financial Results
              • Press Release
              • Financial Highlights
              • Investor Call Transcripts
              • Related Party Transactions
            • Investor's Contact
            • Corporate Governance
            • AGM
            • Postal Ballot
        • News
        • Press Release
        • Careers
            • Life at Hikal
            • Career Opportunities
        • Contact Us
            • Visit us
            • Get in touch
        • Company Announcements
        • Investor Relations > Investor Information >
        • Home >
        • Company Fact Sheet
        • Company Announcements
        • Shareholding Pattern
        • Unclaimed Dividends
        • Transfer Of Shares To IEPF
        • EOGM
        • TDS on Dividend
        • IEPF/Dividend/ Share
        • Investor Services Forms
        PDF

        Hikal Q1FY23 Earnings Call Invite

        PDF

        Reappointment of Mrs. Shivani Bhasin Sachdeva as Independent Director

        PDF

        Trading Window Closure Notice June 2022

        PDF

        Hikal SE Intimation Reopening of Taloja Plant

        PDF

        Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015.Update

        PDF

        Trading Window Closure Notice March 2022

        PDF

        Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Update

        PDF

        Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015

        PDF

        Hikal Q3FY22 Earnings Call Invite

        PDF

        Hikal Outcome of BM 14-02-2022

        PDF

        Trading Window Closure Notice December 2021

        PDF

        Disclosue of change in Directorate

        PDF

        Intimation of revision in Credit Rating Dec-15-2021

        PDF

        Hikal Q2FY22 Earnings Call Invite

        PDF

        Trading Window Closure Notice September 2021

        PDF

        SE Notification on Resumption of Mahad Operations

        PDF

        Hikal Q4FY22 Earnings Call Invite

        PDF

        Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015. Update

        PDF

        Hikal Q1FY22 Earnings Call Invite

        PDF

        Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015

        PDF

        SE Notification on Halt in Mahad Operations

        PDF

        Trading Window June 2021

        PDF

        SE Notification On Resuming Oxygen Supply 10-06-2021

        PDF

        Hikal Intimation of Investors Meet May 2021

        PDF

        Stock Exchange Intimation Non Availability of Industrial Oxygen

        PDF

        Hikal FY21 Q4 Investor & Analyst Meet

        PDF

        Trading Window Qtrend March 2021

        PDF

        Intimation of Schedule of Institutional Investor meeting

        PDF

        Ltr BSE,NSE Earnings Call Invite

        PDF

        Hikal_Q2 FY21 Concall Invite

        PDF

        Credit Rating Intimation 30-07-2018

        PDF

        FY 2020 Q4 Concall Invite

        PDF

        Hikal COVID 19 Stock Exchange Notification 06-04-2020

        PDF

        Hikal COVID 19 Stock Exchange Notification 26-03-2020

        PDF

        Hikal Credit Rating Intimation BSE NSE 06-11-2019

        PDF

        Credit Rating Intimation November-2016

        PDF

        FY 2017-18 Q2 BM Notice

        PDF

        Update on Plant Operations of The Company 28-10-2019

        PDF

        Intimation of Investor Meet September-2016

        PDF

        SAST Disclosure

        PDF

        Credit Rating Intimation August 2017

        PDF

        Intimation of Cutoff date for evoting

        PDF

        FY 2017-18 Q1 BM Notice

        PDF

        Intimation of Investor Meet June-2017

        PDF

        Intimation of Investor Meet June-2016

        PDF

        Submission of Investor Presentation June 2017

        PDF

        Intimation of Book Closure Notice

        PDF

        Disclosure regarding KMPs of Hikal

        PDF

        FY 2016-17 Q4BM Notice

        PDF

        Intimation of Investor Meet February 2017

        PDF

        Submission of Investor Presentation February 2016

        PDF

        Declaration of Int Dividend

        PDF

        FY 2016-17 Q3 BM Notice

        PDF

        Declaration Of Rd For Stock Split

        PDF

        Sale of R&D Property Bangalore

        Established in 1988, Hikal is a company
        built on enduring relationships

        Follow us at  
        COMPANY
        • About us
        • Investor relations
        • Careers
        Media Kit
        OFFERING
        • Pharmaceuticals
        • Crop Protection
        • Specialty Chemicals
        • Research & Technology
        CONTACT US
        • Plant locations
        • Visit us
        • Get in touch

        © 2017. HIKAL Ltd. All rights reserved.

        • Site map
        • Disclaimer
        left

        Media Kit

        EPS FILES

        EPS

        Hikal Logo

        EPS

        Hikal Grayscale Logo

        PNG FILES